Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-16565

Xla Wt + spry2 MO, Sun J et al. (2020)

Experiment + Assay: Xla Wt + spry2 MO + NF 33 (immunohistochemistry)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection spry2 MO3 spry2 (Xla)
 NF stage 32 blastomere D1.1.1
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 33 and 34 to NF stage 33 and 34  
Anatomical Phenotypes: abnormal cell migration , abnormally decreased number of retinal progenitor cell , abnormal retina
Source: Fig. 1. E r1 c3
Article: XB-ART-57260, PubMed